1. Academic Validation
  2. Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

  • Haematologica. 2021 Mar 1;106(3):859-862. doi: 10.3324/haematol.2019.224535.
Franck Morschhauser 1 Kamal Bouabdallah 2 Stephan Stilgenbauer 3 Catherine Thieblemont 4 Sophie de Guibert 5 Florian Zettl 6 Lawrence M Gelbert 7 Kellie P Turner 8 Siva Rama Prasad Kambhampati 8 Li Li 8 Lily Q Li 8 Sean Buchanan 8 Susana Barriga 8 Melissa M Bear 8 Martin Wilhelm 9 Georg Hess 10
Affiliations

Affiliations

  • 1 Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France.
  • 2 Hopital Haut-Levêque, Centre Hospitalier Regional Universitaire de Bordeaux, Pessac, France.
  • 3 Internal Medicine III, Ulm University, Ulm, Germany.
  • 4 Hemato-Oncology Department, Hôpital Saint-Louis and Diderot University, Paris, France.
  • 5 Hôpital de Pontchaillou, Rennes, France.
  • 6 Universitätsmedizin Göttingen, Göttingen, Germany.
  • 7 LMG PharmaTech, LLC., Indianapolis, Indiana, USA.
  • 8 Eli Lilly and Company, Indianapolis, Indiana, USA.
  • 9 Klinikum Nürnberg Nord, Nürnberg, Germany.
  • 10 Universitätsmedizin Mainz, Mainz, Germany.
Figures
Products